fashion -WSS

fashion

author：focus 2025-09-29 18:17:11 - browse：68

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Why the quest to eradicate polio has stumbled

focus

hotspot

WSS

Why an extreme heat and wildfire smoke combination can be so dangerous

FDA official pushes for dedicated emerging pathogens team

A double vaccine crisis is endangering millions of children

AbbVie dramatically boosts its spending on lobbying

HIPAA doesn't protect reproductive records from prosecutors

The struggle to figure out which patients 'deserve' Wegovy

focus

fashion

focus

Psychedelics group wrestles with new pharma identity

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Novavax promises a turnaround & Lilly roils the obesity market

Court strikes down limits on filming of police in Arizona

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

'A game

Walensky prepares to leave CDC — and Congress — behind

White House Covid adviser calls on docs to combat misinformation

Affirmative action in medical school literally saved lives

White House launches permanent pandemic office

explore

7 of the most gruesome medical devices in history

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Death toll from an explosion and collapse of a Paris building in June climbs to 3

CDC backtracks, saying fully vaccinated people can go maskless indoors

Providers still hesitate to prescribe buprenorphine, study finds

focus

hotspot

leisure time

entertainment